Skip to main content
. 2019 Mar 27;10:571. doi: 10.3389/fimmu.2019.00571

Figure 2.

Figure 2

Correlation data of clinical markers in patients with type-2 diabetes and ANXA1. (A) Correlation of plasma CRP with BMI in diabetic patients. (B) Correlation of plasma ANXA1 levels with BMI in diabetic patients. (C) Correlation of plasma ANXA1 levels with CRP in diabetic patients. (D) Correlation of CRP with cholesterol in diabetic patients. (E) Correlation of CRP with LDL in diabetic patients. (F) Plasma ANXA1 levels in patients with diabetes ± CKD. (A–E) display 95% confidence intervals are displayed of the linear regression and significance estimated using Fishers F-test p < 0.05 was deemed significant.

HHS Vulnerability Disclosure